United Therapeutics pays $800M-plus to grab Arena?s PhIII PAH drug via @endpts

United Ther?a?peu?tics $UTHR is pay?ing an $800 mil?lion cash up?front in a big bet to stay among the lead?ers in pul?monary ar?te?r?ial hy?per?ten?sion, grab?bing rights to Arena Phar?ma?ceu?ti?cals? ra?linepag in the deal. And the ex?ec?u?tive crew is will?ing to add hun?dreds of mil?lions more in mile?stones if they can stay on track through to an ap?proval and com?mer?cial?iza?tion.

Source: United Therapeutics pays $800M-plus to grab Arena?s PhIII PAH drug ? Endpoints News